About Valerie Delva

Valerie Delva is the SVP, Director, Health Strategy, North America based in Ketchum's New York office. She leads health strategy and ensures client programming is integrated, cross-functional and taps the many categories of expertise Ketchum has as an agency.

Author Archive | Valerie Delva

Creativity Designed to SOLVE Problems

Last month, I found myself preparing to present at the United Nations alongside a group of top social impact entrepreneurs. We were all finalists in a global competition by the Massachusetts Institute of Technology (MIT) non-profit SOLVE, which focuses on “solving the world’s most pressing challenges through open innovation and partnership.” Many of the finalists had businesses and start-ups that were years in the making, and were regarded as leaders in their respective fields of refugee education, carbon emissions and chronic diseases.

My colleague Anne Marie Kearns and I came up with an innovative cancer literacy approach that leveraged artificial intelligence to help address cancer burden in developing countries. I truly believe in the idea. It could potentially impact lives and, suddenly, it all felt real once I took to the stage.

Continue Reading

Healthcare in 2017: Yes, your doctor will be human. No, fake news cannot be ignored.

From the annual J.P. Morgan Healthcare Conference to the World Economic Forum meeting in Davos, this month kicked off a series of environment-setting and industry-shaping conferences for the year. So like many communications professionals taking a look at the year ahead for clients and their organizations, I made my way through a volume of 2017 trends, predictions, insights and counter predictions from various experts (a good, quick read is the PwC Top Health Industry Issues of 2017: A Year of Uncertainty and Opportunity).

As one would expect, we will continue to see drug pricing scrutiny, health reform uncertainties, cross-sector collaborations, and a fervent focus on the role of artificial intelligence (AI) in medicine. We will also experience a new level of excitement around the promise of CAR T-cell therapies (FierceBiotech shares insights on upcoming milestones here) and the high expectations for CRISPR (I particularly like this VOX overview).

Continue Reading

In the War on Cancer, We All Play a Role in Scaling Progress

Ketchum recently supported The Economist Events team as the PR agency for their second annual War on Cancer Forum: Scaling Progress. The event brought together patient advocates and cross-sector experts from technology, finance, analytics, policy, medicine and more for a full day of brainstorming, dialogue and debate.

As a health communicator, sitting in a room with leaders from such diverse backgrounds served as a critical reminder on the counsel we need to provide: When we advise on strategy and craft communications campaigns, we need to advocate for and put into practice more integrated, cross-sector approaches to PR. This is especially crucial in healthcare.

Continue Reading